Active Surveillance Prostate Cancer Video Chat, February 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Ray E 8:25 PM
i know but if I just cut in I think others will to but if you prefer I will cut in
AnCan – Rick 8:39 PM
Dr. Sanoj Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
Hugh -Houston 8:48 PM
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:49 PM
Dr. Michael Liss https://providers.ucsd.edu/details/1477733012/urology-cancer
Active Surveillance Prostate Cancer Video Chat, January 28th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Eric- Atlanta 8:49 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:50 PM
Recent article on finasteride/dutasteride and disease progression https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822868?guestAccessKey=51fc10c5-3b12-4e00-903b-b8611dfbe9a5&utm_source=silverchair&utm_campaign=jama_network&utm_content=onc_weekly_highlights&utm_medium=email&adv=000002836268&mc_cid=c06ec53f6d&mc_eid=838454d636
Eric- Atlanta 9:18 PM
Latest April 2025 NCCN Guidelines for Early PCa: https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
AnCan – Rick 9:19 PM
Tx Dr. Dan – I recall there was something out there. Thanks
AnCan – Rick 9:22 PM
Early stage Guidelines https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
Hector 9:44 PM
This is now at the hypothetical level, no conclusive evidence yet: NPR: Could mRNA vaccines help fight cancer? https://www.npr.org/2022/06/05/1103178829/could-mrna-vaccines-help-fight-cancer
Active Surveillance Prostate Cancer Video Chat, January 14th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Phil-Toronto 8:05 PM
Prostate Cancer Journal Club for Patients tomorrow at 9:00am ” can Micro U/S replace MRI for PCa Diagnosis Matt Cooperberg Laurence Klotz meded.ucsf.edu
Martin 8:13 PM
Brian, my email is martinuthe14@gmail.com. I would love to hear about your acqua ablation. Thx!
BJ 8:24 PM
Hi guys anyone have a link for the mentioned webinar tomorrow?
Phil-Toronto 8:25 PM
meded.ucsf.edu. If you google the link it should take you to the registration for the webinar tomorrow
Phil-Toronto 8:36 PM
aquablation vs. HOLEP https://www.perplexity.ai/search/80078b6b-bae2-4382-96d6-4035a1f29ba0
BJ 8:40 PM
Dan P: You mentioned a book at the beginning. if you can put the name of it on the chat. Ty
AnCan – Rick 8:50 PM
Dr. Sanjay Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
BJ 9:01 PM
Need to drop off. Thanks all for sharing so much.
AnCan – Rick 9:06 PM
Helfand webinar on AS on AnCan https://ancan.org/webinar-active-surveillance-beyond-with-dr-brian-helfand/
AnCan – Rick 9:13 PM
@RogerNorris…. PROSTATE, not prostrate.
Active Surveillance Prostate Cancer Video Chat, December 10th, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Hugh -Houston
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
Derek
👍
Eric- Atlanta
PROMISE/COLOR Genetic Study w/ANCAN affiliate link: https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar
Eric- Atlanta
Men Speaking Freely: https://ancan.org/series/men-speaking-freely/
Eric- Atlanta
Food & Nutrition: https://ancan.org/wp-content/uploads/2020/11/Prostate-Ca-AS_Nov-2020.pdf
Eric- Atlanta
2nd Opinions for MRIs: Botimage AI for MRIs: https://botimageai.com/prostatid/ ~$250, can also be used for biopsy targeting guidance -Second opinion of MRI from Johns Hopkins Images and Reports for Providers | Johns Hopkins Radiology (hopkinsmedicine.org) Email: eradiologycenter@jhmi.edu Phone: 443-287-7378 Fax: 443-769-1210 NIH 2nd Opinion MRI (no fees): Choyke, Peter (NIH/NCI) Radiologist pchoyke@mail.nih.gov -Accolade Radiology NY, PA https://accoladeradiology.com/mritap.html Radiology Check (Switzerland) https://radiologycheck.com/en
AnCan Bill
Got to drop gentlemen. Thanks for helping out Martin (and everyone else). Take care.
Martin Uthe
thank you. Bill!
Eric- Atlanta
Thank you Bill
AnCan – rick
Great advice, Dan G
Martin Uthe
Hi guys- have to run. Thank you so much for your time and support. Talk to you on Friday, Howard.
Howard Wolinsky
Dr. Eggener UCLA
Howard Wolinsky
FYI on perineural invasion–sounds scary–https://howardwolinsky.substack.com/p/part-ii-the-perineural-invaders?utm_source=publication-search
Joel _ Manassas, VA
Much appreciate all the helpful discussion. Best to all
Active Surveillance Prostate Cancer Video Chat, November 26th, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Chris L. (Windsor, CA)
Gut microbiome & phytochemical rich diet: YouTube: https://www.youtube.com/watch?v=0vR0QL3oR2k
Chris L. (Windsor, CA)
Asco highlights: https://www.urotoday.com/conference-highlights/asco-gu-2025/asco-gu-2025-prostate-cancer/158203-asco-gu-2025-gut-health-and-prostate-cancer-the-influence-of-a-specific-phytochemical-rich-food-capsule-plus-or-minus-a-probiotic-prebiotic-blend-on-symptoms-and-progression-a-randomised-double-blind-placebo-controlled-trial.html
Eric- Atlanta
https://howardwolinsky.substack.com/p/breaking-transperineal-biopsies-find?utm_source=publication-search
Bill Harris (Los Angeles)
Hi Rick. Hope all is well
Eric- Atlanta
Seminar link and info: https://aspatients.org/event/transperineal-vs-transrectal-biopsy-2025/
Eric- Atlanta
“Key Clinical Trials Driving the Debate Recent trials have brought new insights: Dr. Jim Hu (PREVENT, 2024): Zero infections with TP vs 1.4% with TR, suggesting a reduced risk of sepsis. Dr. Alastair Lamb and Dr. Richard Bryant (TRANSLATE, 2025): TP detected 5–6% more clinically significant cancers (Grade Group ≥ 2) and often required no antibiotics. Dr. Badar Mian (PRoBE-PC, 2024): Both methods proved safe and effective, giving patients more choice. Together, these studies have reshaped how experts think about prostate biopsy safety.”
Ray E Santa Monica Ca
https://www.perplexity.ai/search/262e8d77-95e5-4fef-aa07-9b7a313c25f1
Ray E Santa Monica Ca
Above is a run down on TP vs Transrectal biopsy
Bill (VA)
Walter Reed now performing TP
AnCan – rick
AnCan Prostate Cancer Debate Aug 2022 Dr. George vs Dr. Kaye https://ancan.org/webinar-prostate-cancer-biopsies-the-great-debate/
Bill Harris (Los Angeles)
Bill Harris wmharris@gmail.com
Bill Harris (Los Angeles)
(new inherited mutation group
